Clinical trial
Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia
NCT00169091 · Harvard Medical School (HMS and HSDM), Other · Terminated
Key facts
| NCT number | NCT00169091 |
|---|---|
| Title | Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia |
| Official title | Clozapine or Haloperidol in First Episode Schizophrenia |
| Lead sponsor | Harvard Medical School (HMS and HSDM), Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH Dartmouth-Hitchcock Medical Center Commonwealth Research Center, Massachusetts Novartis Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Clozapine, Haloperidol |
| Enrollment | 32 |
| Start date | Mar 1, 1996 |
| Primary completion | Sep 1, 2003 |
| Completion | Oct 1, 2003 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 7, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: